Extranodal NK-T-cell lymphoma future or investigational therapies
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma future or investigational therapies |
|
FDA on Extranodal NK-T-cell lymphoma future or investigational therapies |
|
CDC on Extranodal NK-T-cell lymphoma future or investigational therapies |
|
Extranodal NK-T-cell lymphoma future or investigational therapies in the news |
|
Blogs on Extranodal NK-T-cell lymphoma future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
High dose chemotherapy and autologous haematopoietic stem cell transplantation is used for varying types of lymphoma, however there is a lac of such experience in treating extranodal NK-T cell lymphoma. Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. Autologous transplantation appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation.
Future or Investigational Therapies
High dose chemotherapy and autologous haematopoietic stem cell transplantation is used for varying types of lymphoma, however there is a lac of such experience in treating extranodal NK-T cell lymphoma.[1] Further clinical trials are needed to prove that this therapy is handy and can be used as a method of therapy. Autologous transplantation appears to provide a great survival benefit only for those who attended a complete remission at the time of transplantation.
References
- ↑ Liang, Raymond (2009). "Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type". British Journal of Haematology. 147 (1): 13–21. doi:10.1111/j.1365-2141.2009.07802.x. ISSN 0007-1048.